MARKET

OBIO

OBIO

Orchestra BioMed Holdings Inc
NASDAQ
3.875
+0.045
+1.17%
Opening 15:32 02/17 EST
OPEN
3.830
PREV CLOSE
3.830
HIGH
3.944
LOW
3.770
VOLUME
48.71K
TURNOVER
--
52 WEEK HIGH
5.98
52 WEEK LOW
2.200
MARKET CAP
218.80M
P/E (TTM)
-2.1311
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at OBIO last week (0209-0213)?
Weekly Report · 1d ago
Orchestra BioMed Adopts 2026 Performance-Driven Executive Compensation Plan
TipRanks · 3d ago
Orchestra BioMed Grants Stock Options to New Employees Under Inducement Plan
Reuters · 3d ago
ORCHESTRA BIOMED ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)
Reuters · 3d ago
Weekly Report: what happened at OBIO last week (0202-0206)?
Weekly Report · 02/09 09:22
Orchestra Biomed Unveils Vision for Growth With Updates on Pivotal Cardiovascular Trials and Strategic Partnerships
Reuters · 02/05 19:06
Analysts Offer Insights on Healthcare Companies: Orchestra BioMed Holdings (OBIO), LENZ Therapeutics (LENZ) and Amgen (AMGN)
TipRanks · 02/04 12:04
Weekly Report: what happened at OBIO last week (0126-0130)?
Weekly Report · 02/02 09:22
More
About OBIO
Orchestra BioMed Holdings, Inc. is a biomedical innovation company. The Company’s lead product candidates include Atrioventricular Interval Modulation (AVIM) therapy for the treatment of hypertension (HTN), the leading risk factor for death worldwide and the Virtue Sirolimus AngioInfusion Balloon (Virtue SAB) for the treatment of atherosclerotic artery disease, the leading cause of mortality worldwide. The Company develops bioelectronic therapies based on patented Cardiac Neuromodulation Therapy (CNT) technology. The AVIM is a bioelectronic therapy candidate designed to substantially and persistently lower blood pressure. Its Virtue SAB is a proprietary drug/device combination product candidate for the treatment of artery disease that is designed to deliver a proprietary, investigational, extended-release formulation of sirolimus (SirolimusEFR) to the vessel wall during balloon angioplasty without the need for balloon coating or a permanent implant.

Webull offers Orchestra Biomed Holdings Inc stock information, including NASDAQ: OBIO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OBIO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading OBIO stock methods without spending real money on the virtual paper trading platform.